# Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

> **NCT03090516** · PHASE2,PHASE3 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 240 (estimated)

## Conditions studied

- Alzheimer's

## Interventions

- **DRUG:** Ginkgo biloba dispersible tablets
- **DRUG:** Donepezil
- **DRUG:** Ginkgo biloba dispersible tablets and Donepezil

## Key facts

- **NCT ID:** NCT03090516
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-10
- **Primary completion:** 2020-03-10
- **Final completion:** 2020-03-10
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090516, "Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03090516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*